Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-28T10:28:09.319Z Has data issue: false hasContentIssue false

Drug management of disturbed behaviour by psychiatrists

Published online by Cambridge University Press:  02 January 2018

J.G. Cunnane*
Affiliation:
Chesterfield & North Derbyshire Royal Hospital, Chesterfield S44 5BL
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The aggressive, acutely psychotic patient may present in many medical settings. Drugs are usually necessary to avert or abort a crisis yet specific guidance on such management is lacking from standard psychiatric texts. Consultant psychiatrists have a crucial advisory role in these situations but information on their prescribing habits has not been published. This study aims to determine whether there is any consensus on the drug management of the aggressive, acutely psychotic patient by consultant psychiatrists.

Type
Original papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1994

References

Baldessarini, R.J., Katz, B. & Cotton, P. (1984) Dissimilar dosing with high-potency and low-potency neuroleptics. American Journal of Psychiatry, 141, 748752.Google Scholar
Baldessarini, R.J., Cohen, B.M. & Teicher, M.H. (1988) Significance of neuroleoptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry, 45, 7991.CrossRefGoogle ScholarPubMed
Dubin, W.R. & Feld, J.A. (1989) Rapid tranquillization of the violent patient. American Journal of Emergency Medicine, 7, 313320.Google Scholar
Kane, J.M. (1987) Treatment of schizophrenia. Schizophrenia Bulletin, 13, 133156.Google Scholar
Rifkin, A., Doddi, S., Karajgi, B., Dorenstein, M. & Wachspress, M. (1991) Dosage of haloperidol for schizophrenia. Archives of General Psychiatry, 48, 166170.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.